South Dakota Administrative Rules
Title 44 - Department of Health
Article 44:70 - Assisted living centers
Chapter 44:70:04 - Management and administration
Section 44:70:04:10 - Tuberculin screening and testing requirements
Current through Register Vol. 50, page 114, March 25, 2024
Each facility shall develop criteria to screen healthcare personnel or residents for Mycobacterium tuberculosis (TB) based on the guidelines issued by Centers for Disease Control and Prevention. Each facility shall establish policies and procedures for conducting TB risk assessment that include the key components of responsibility, surveillance, containment. The frequency of repeat screening shall depend upon annual facility risk assessment results. Any resident identified as asymptomatic upon admission as short stay or anticipated stay of thirty days or less is not required to have tuberculin skin test or a TB blood assay test.
Tuberculin screening requirements for healthcare personnel and residents are as follows:
(1) Each healthcare personnel or resident shall receive an initial individual TB risk assessment that is documented and the two-step method of tuberculin skin test or a TB blood assay test to establish a baseline within twenty-one days of employment or admission to a facility. Any two documented tuberculin skin tests completed within a twelve-month period prior to the date of admission or employment are considered two-step. A TB blood assay test completed within a twelve-month period prior to the date of admission or employment is considered an adequate baseline test. Skin testing or TB blood assay tests are not necessary if a new healthcare personnel or resident transfers from one licensed healthcare facility to another licensed healthcare facility within this state if the facility received documentation of the last skin or blood assay TB testing completed within the prior twelve months. Skin testing or TB blood assay tests are not necessary if documentation is provided of a previous positive reaction to either test. Any healthcare personnel or resident who has a newly recognized positive reaction to the skin or TB blood assay test shall have a medical evaluation and a chest X-ray to determine the presence or absence of the active disease;
(2) Each healthcare personnel or resident who provides documentation of a positive reaction to the tuberculin skin or a TB blood assay test shall have a medical evaluation and chest X-ray to determine the presence or absence of the active disease; and
(3) Each healthcare personnel or resident with a history of a positive reaction to the tuberculin skin test or TB blood assay test shall be evaluated annually by a physician, physician assistant, nurse practitioner, clinical nurse specialist, or a nurse and a record maintained of the presence or absence of symptoms of TB. If this evaluation results in suspicion of active tuberculosis, the healthcare personnel or resident shall be referred for further medical evaluation to confirm the presence or absence of tuberculosis;
(4) Each facility shall consider the use of annual TB screening for personnel at increased occupational risk and residents identified at increased risk for TB because of current or planned immunosuppression; and
(5) All healthcare personnel shall receive TB education annually. TB education shall include information on TB risk factors, the signs and symptoms of TB disease, and TB infection control policies and procedures.
General Authority: SDCL 34-12-13(1)(5), 34-22-9(8).
Law Implemented: SDCL 34-12-13(1)(5).
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. "Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report," May 17, 2019 / 68(19);439-443.
